3:51 PM ET
8-K
Divestiture
Mangoceuticals Divestiture to Two accredited investors for $2.5M
Mangoceuticals, Inc. sold a 25% ownership stake in its subsidiary, MangoRx IP Holdings, LLC, to two accredited investors for $2.5 million. The transaction was structured at the subsidiary level to raise capital for the commercialization of its antiviral technology (MGX-0024) without diluting the parent company's common stock.
- Value
- $2.5M
- Counterparty
- Two accredited investors